1.
Tronieri JS, Wadden T, Sugimoto D, T. Lund M, Auerbach P, Endahl L, et al. WEIGHT LOSS WITH LIRAGLUTIDE 3.0 mg VERSUS PLACEBO FOR INDIVIDUALS WHO ADHERE TO THE TRIAL DRUG: A SECONDARY ANALYSIS FROM SCALE IBT. J ASEAN Fed Endocr Soc [Internet]. 2022 Jun. 8 [cited 2024 Nov. 21];34(2):46-7. Available from: https://asean-endocrinejournal.org/index.php/JAFES/article/view/2017